Stockscreener 앱 받기
6.72
1.05%
0.07
시간 외 거래:
6.72
전일 마감가:
$6.65
열려 있는:
$6.71
하루 거래량:
567.00K
Relative Volume:
0.48
시가총액:
$435.59M
수익:
$202.09M
순이익/손실:
$-61.69M
주가수익비율:
-6.2222
EPS:
-1.08
순현금흐름:
$-35.64M
1주 성능:
-2.61%
1개월 성능:
+3.07%
6개월 성능:
-27.04%
1년 성능:
-39.51%
1일 변동 폭
$6.58
$6.77
1주일 범위
$6.565
$6.93
52주 변동 폭
$5.71
$17.12
Evolus Inc Stock (EOLS) Company Profile
명칭
Evolus Inc
전화
(949) 284-4555
주소
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
EOLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
6.72 | 431.05M | 202.09M | -61.69M | -35.64M | -1.08 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 다운그레이드 | Needham | Buy → Hold |
| 2025-04-17 | 개시 | BTIG Research | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-06-23 | 개시 | Needham | Buy |
| 2022-05-12 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-20 | 업그레이드 | Truist | Hold → Buy |
| 2021-05-06 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-04-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-24 | 다운그레이드 | Truist | Buy → Hold |
| 2020-07-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-02-06 | 재개 | Mizuho | Buy |
| 2019-11-26 | 개시 | SVB Leerink | Outperform |
| 2019-09-05 | 재개 | Mizuho | Buy |
| 2019-06-28 | 개시 | Wells Fargo | Market Perform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2019-01-29 | 개시 | Stifel | Buy |
모두보기
Evolus Inc 주식(EOLS)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Evolus (EOLS) - The Globe and Mail
Discipline and Rules-Based Execution in EOLS Response - Stock Traders Daily
Avelar Rui, Evolus officer, sells $16k in EOLS stock By Investing.com - Investing.com Nigeria
Evolus CEO Moatazedi sells $75k in shares By Investing.com - Investing.com South Africa
Avelar Rui, Evolus officer, sells $16k in EOLS stock - Investing.com
Insider Selling: Evolus (NASDAQ:EOLS) Insider Sells 10,539 Shares of Stock - MarketBeat
Rui Avelar Sells 2,261 Shares of Evolus (NASDAQ:EOLS) Stock - MarketBeat
Evolus CEO Moatazedi sells $75k in shares - Investing.com India
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
Evolus, Inc. $EOLS Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
Big Picture: Does Evolus Inc stock trade at a discount to peersPortfolio Update Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn
Evolus' (EOLS) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham Reiterates Evolus (EOLS) Hold Recommendation - Nasdaq
Needham Reiterates Hold Rating for Evolus (EOLS) | EOLS Stock Ne - GuruFocus
Mizuho cuts Evolus (EOLS) estimates for Jeuveau/Evolysse on waning consumer sentiment and inflationary pressure on elective aesthetics - MSN
Net current asset value per share of Evolus, Inc. – BER:EVL - TradingView — Track All Markets
Trading the Move, Not the Narrative: (EOLS) Edition - Stock Traders Daily
EV Market: Why Evolus Inc. stock is a must watch in 2025Earnings Growth Summary & Consistent Return Investment Signals - Улправда
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Will Evolus Inc. (EVL) stock benefit from sector leadershipInflation Watch & Risk Controlled Stock Alerts - ulpravda.ru
Why Evolus Inc. stock is rated strong buyTrade Risk Summary & Consistent Profit Trading Strategies - DonanımHaber
Will Evolus Inc. stock continue dividend increasesJuly 2025 Spike Watch & Capital Efficient Trade Techniques - DonanımHaber
Why Evolus Inc. stock is a must watch in 2025Insider Selling & Precise Trade Entry Recommendations - Улправда
Can Evolus Inc. stock deliver strong Q4 earningsJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - Улправда
Can Evolus Inc. stock beat market expectations this quarterGlobal Markets & Daily Chart Pattern Signals - Улправда
Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS) - Seeking Alpha
Evolus, Inc. (NASDAQ:EOLS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Mizuho Cuts Evolus (EOLS) Estimates for Jeuveau/Evolysse on Waning Consumer Sentiment and Inflationary Pressure on Elective Aesthetics - Insider Monkey
20 Stocks That Will Double in 2026 - Insider Monkey
2,435,550 Shares in Evolus, Inc. $EOLS Bought by Frazier Life Sciences Management L.P. - MarketBeat
Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal
Frontier Capital Management Co. LLC Buys 457,533 Shares of Evolus, Inc. $EOLS - MarketBeat
Evolus, Inc. Earnings Call Highlights Growth and Resilience - MSN
Jump Financial LLC Grows Stock Position in Evolus, Inc. $EOLS - MarketBeat
Mizuho reaffirms Evolus stock rating at Outperform amid early signs of market stabilization - Investing.com Canada
Evolus Navigates a Path to Profitability Amidst Quarterly Challenges - AD HOC NEWS
(EOLS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Evolus price target lowered to $19 from $20 at Mizuho - MSN
Stonepine Capital Management LLC Has $8.44 Million Holdings in Evolus, Inc. $EOLS - MarketBeat
How Evolus Inc. (EVL) stock compares with tech leadersWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Mizuho lowers Evolus stock price target on consumer sentiment concerns By Investing.com - Investing.com Canada
Why Evolus Inc. stock attracts global investorsJuly 2025 Volume & Community Consensus Picks - Newser
Mizuho lowers Evolus stock price target on consumer sentiment concerns - Investing.com India
Is Evolus Inc. stock a defensive play in 2025July 2025 Recap & Technical Pattern Based Buy Signals - Newser
How Evolus Inc. (EVL) stock behaves in tightening cyclesJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser
How cyclical is Evolus Inc. (EVL) stock compared to rivalsEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
How Evolus Inc. (EVL) stock reacts to stronger dollarQuarterly Market Review & Verified Entry Point Signals - Newser
Evolus Inc (EOLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Evolus Inc 주식 (EOLS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Avelar Rui | See Remarks |
Dec 22 '25 |
Sale |
7.15 |
2,261 |
16,168 |
356,821 |
| Yamagishi-Dressler Tomoko | Chief Marketing Officer |
Aug 22 '25 |
Sale |
7.51 |
5,722 |
42,972 |
89,949 |
| Stewart Brady | Director |
Aug 15 '25 |
Buy |
6.82 |
30,000 |
204,486 |
88,629 |
| MOATAZEDI DAVID | See Remarks |
Jun 13 '25 |
Sale |
10.05 |
111,323 |
1,119,141 |
381,509 |
| MOATAZEDI DAVID | See Remarks |
Jun 16 '25 |
Sale |
9.89 |
16,582 |
164,054 |
364,927 |
2.19%
0.08%
자본화:
|
볼륨(24시간):